SB 302, which took effect on July 1, 2018, now allows telehealth providers to prescribe any schedule II or III controlled substance, except opioids, for the treatment of a person with a psychiatric disability or substance use disorder, including medication-assisted treatment. “Medication-assisted treatment” is defined in the law as the use of medications approved by the federal Food and Drug Administration, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. A telehealth provider who wishes to prescribe a controlled substance must still comply with the requirements of the Ryan Haight Online Pharmacy Consumer Protection Act. One important requirement of the Act is that practitioners have conducted at least one in-person medical evaluation of the patient prior to issuing a prescription for a controlled substance.
Click Here to read entire Legal Alert.
For more information on the above legislation, please contact the Garfunkel Wild attorney with whom you usually work.